Galectin Therapeutics

Norcross, Georgia, USA
37 Total Employees

Similar Companies Hiring

Software • Pharmaceutical • Healthtech
11 Offices
69000 Employees
Telehealth • Social Impact • Pharmaceutical • Healthtech
New York City, NY
13 Employees
Pharmaceutical • Logistics • Healthtech
12 Offices
46000 Employees

Galectin Therapeutics looks to help patients with NASH cirrhosis and cancer. Galectin’s lead drug (GR-MD-02, or belapectin) is a galectin-3 inhibitor.

Galectin Therapeutics Offices

OnSite Workspace

Employees work from physical offices.

Typical time on-site:
Norcross, Georgia, USA